Unit:
Κατεύθυνση Χειρουργική ΟγκολογίαLibrary of the School of Health Sciences
Supervisors info:
Θεοδοσόπουλος Θεοδόσιος, Αναπληρωτής Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ, Επιβλέπων
Πολυμενέας Γεώργιος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Φραγκουλίδης Γεώργιος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Original Title:
Θεραπευτικά πρωτόκολλα ενδοπορικού Ca μαστού (DCIS)
Translated title:
Treatment protocols in ductal carcinoma in situ (DCIS)
Summary:
A retrospective study on patients of various ages with DCIS and the therapeutic protocols followed in each case. Participants were treated surgically with tumor removal or mastectomy based on criteria such as tumor size, histologic type, grade, range, mammographic characteristics, age and patient desire. Patients with positive receptors (ER-PR) received postoperative Tamoxifen or aromatase inhibitors (in postmenopausal patients). Most patients who did not undergo a mastectomy were treated with postoperative radiotherapy. Surgical intervention of the axilla region, either as an axillary lymph node drainage or as a guard lymph node biopsy, was performed in patients at high risk of coexisting invasive disease and in patients undergoing mastectomy. Postoperative follow-up of patients included annual mammography or sometimes breast MRI. In conclusion, DCIS is a disease of good prognosis, the outcome of which depends on the size of the lesion, the expression or not of hormonal receptors, and the tumor grade.
Main subject category:
Health Sciences
Keywords:
Breast cancer, Treatment, DCIS, Prognosis
